Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey K Griffith

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|July 22, 2006
Telomeres: prognostic markers for solid tumorsMarco Bisoffi, Christopher M Heaphy, Jeffrey K Griffith
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic significance of allelic imbalance in cancerChristopher M Heaphy, Marco Bisoffi, Jeffrey K Griffith
Breast Cancer Research and Treatment|August 18, 2009
Mammary field cancerization: molecular evidence and clinical importanceChristopher M Heaphy, Jeffrey K Griffith, Marco Bisoffi
Biotechniques|July 26, 2002
Chemiluminescent measurement of telomere DNA content in biopsiesColleen A Fordyce, Christopher M Heaphy, Jeffrey K Griffith
Prostate Cancer|June 6, 2012
Markers of field cancerization: proposed clinical applications in prostate biopsiesKristina A Trujillo, Anna C Jones, Jeffrey K Griffith, et al.
Cancer Medicine|January 24, 2013
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomasKimberly S Butler, William C Hines, Christopher M Heaphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Telomere DNA content predicts breast cancer-free survival intervalChristopher M Heaphy, Kathy B Baumgartner, Marco Bisoffi, et al.
Molecular Cancer Research : MCR|September 24, 2005
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissuesWilliam C Hines, Alexandra M Fajardo, Nancy E Joste, et al.
Molecular and Cellular Biochemistry|November 23, 2006
A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma modelZhihe Liu, Guanghua Wan, Christopher Heaphy, et al.
Cancer Cell International|June 2, 2006
Protease nexin-1 expression is altered in human breast cancerBritny J Candia, William C Hines, Christopher M Heaphy, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|July 22, 2006
Telomeres: prognostic markers for solid tumorsMarco Bisoffi, Christopher M Heaphy, Jeffrey K Griffith
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic significance of allelic imbalance in cancerChristopher M Heaphy, Marco Bisoffi, Jeffrey K Griffith
Breast Cancer Research and Treatment|August 18, 2009
Mammary field cancerization: molecular evidence and clinical importanceChristopher M Heaphy, Jeffrey K Griffith, Marco Bisoffi
Biotechniques|July 26, 2002
Chemiluminescent measurement of telomere DNA content in biopsiesColleen A Fordyce, Christopher M Heaphy, Jeffrey K Griffith
Prostate Cancer|June 6, 2012
Markers of field cancerization: proposed clinical applications in prostate biopsiesKristina A Trujillo, Anna C Jones, Jeffrey K Griffith, et al.
Cancer Medicine|January 24, 2013
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomasKimberly S Butler, William C Hines, Christopher M Heaphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Telomere DNA content predicts breast cancer-free survival intervalChristopher M Heaphy, Kathy B Baumgartner, Marco Bisoffi, et al.
Molecular Cancer Research : MCR|September 24, 2005
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissuesWilliam C Hines, Alexandra M Fajardo, Nancy E Joste, et al.
Molecular and Cellular Biochemistry|November 23, 2006
A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma modelZhihe Liu, Guanghua Wan, Christopher Heaphy, et al.
Cancer Cell International|June 2, 2006
Protease nexin-1 expression is altered in human breast cancerBritny J Candia, William C Hines, Christopher M Heaphy, et al.
Pageof 3